Bone metastases of bronchial cancer
T. Adzic, G. Radosavljevic-Asic, N. Samardzic, S. Filipovic, D. Jovanovic (Belgrade, Yugoslavia)
Source: Annual Congress 2002 - Lung cancer: epidemiology and clinical characteristics
Session: Lung cancer: epidemiology and clinical characteristics
Session type: Thematic Poster Session
Number: 576
Disease area: Thoracic oncology
Abstract During 2000, 1044 pts with malignant lung tumors were analyzed, out of whom 47(5%) had bone metastases, 36(77%) males aged 58 years on average and 11(23%) females mean age 61 years. The diagnosis of malignant tumor was made in 24(51%) by bronchologic tests, in 4(9%) by FNAB of lung changes, in 4(9%) cases by bone biopsy, in 3(6%) pts by exploratoy thoracotomy, in 2(4%) by lymph node biopsy, while diagnosis could not be made in 10(21%) cases. Histopathologic findings were as follows: Adenocarcinoma was found in 18(38%)pts, Squamous Cell Carcinoma in 14(30%), Small Cell Lung Carcinoma in 4(9%), Bronchioalveolar Carcinoma in 1(2%) patient, and no diagnosis was made in 10(21%) cases. After the surgery, bone metastases were detected in 6 pts, and accordingly, symptomatic treatment was applied in 3 pts, one received chemotherapy, one had radiation therapy, and there was one lethal outcome. The remaining 10(21%) cases were administered chemotherapy, 3(6%) pts were given radiation therapy, 1(2%) received combined chemo and radiation therapy, 22(47%) of them had symptomatic treatment, while 5(11%) cases died during the diagnosis. The diagnosis was based on bone radiography and scintigraphy. Higher level of alkaline phosphatase in serum was found in all pts(100%). The bones most frequently involved were: ribs, vertebrae, humerus and femur. It may be concluded that Adenocarcinoma was the most frequent type of tumor to metastasize in bones, the most common aspect of therapy was palliative treatment, lethal outcome during diagnosis occurred in 5(11%) cases, while pamidronate was successfully applied in one patient who had undergone surgery and received chemotherapy.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Adzic, G. Radosavljevic-Asic, N. Samardzic, S. Filipovic, D. Jovanovic (Belgrade, Yugoslavia). Bone metastases of bronchial cancer. Eur Respir J 2002; 20: Suppl. 38, 576
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Detection of bone metastases in patients with lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001
Survival of lung cancer patients with bone metastases Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
Bone metabolic markers in detecting bone metastasis of lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Usefulness of bone metabolic markers in the bone metastasis from lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 269s Year: 2002
The role of bisphosphonates in lung cancer patients with bone metastases Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007
Splenic metastasis of lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 91s Year: 2006
Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry Source: Eur Respir J 2006; 28: Suppl. 50, 782s Year: 2006
Brain metastases in lung cancer patients Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients. Year: 2019
Palliation of bone metastases-related pain in lung carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003
Detection of bone metastases in patients with NSCLC Source: Eur Respir J 2002; 20: Suppl. 38, 185s Year: 2002
Unusual metastases in lung cancer Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
Lung metastases revealing medulloblastoma Source: Eur Respir J 2005; 26: Suppl. 49, 539s Year: 2005
Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
Endobronchial metastasis from breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 77s Year: 2006
Endobronchial metastasis from prostate cancer Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
Lung cancer after lung transplantation Source: Annual Congress 2007 - Complications and success in lung transplantation Year: 2007
Lung carcinoma and verthebral column metastases Source: Eur Respir J 2007; 30: Suppl. 51, 428s Year: 2007
Lung cancer and pleural mesothelioma Source: Eur Respir Monogr 2014; 65: 48-60 Year: 2014